StreetAlpha.app
Home › Stocks › CRVL

Corvel Corp (CRVL)

$88.28
▲ +1.05%
LAST CLOSE · NOV 20

CorVel provides medical cost management and claims services to insurers and employers for workers' compensation, auto and group health. It last closed at $88.28 on Nov 20, up 1.05% on the day. The next earnings report for CRVL is expected around Tue, Feb 2, 2027, before the open. For the quarter ended Sep 2026, CRVL reported EPS of $0.67 on revenue of $267.1M, with revenue up 11.5% from a year ago. Over its last 8 reports the stock moved an average of 7.1% the session after earnings. Over the last 12 months CRVL insiders bought $0 of stock on the open market and sold $22.5M, according to SEC Form 4 filings.

AI Auto Pilots
Is CRVL in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold CRVL.

Key Stats

Last 12 months
Results
Revenue
$1.0B
+8.3% vs a year ago
Net income
$121.5M
+15.4% vs a year ago
EPS (diluted)
$2.39
+18.3% vs a year ago
Free cash flow
$127.9M
12.6% margin
Valuation
Market cap
$4.4B
50.3M shares
P/E
36.9
Price over 12 month EPS
Price to sales
4.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$270.0M
At Sep 30
Shareholder equity
$430.5M
Buybacks
$74.3M
Last 12 months
Fiscal year endsMarch
ExchangeNasdaq
Financials history
FY2022: $646.2M$646.2MFY2022FY2023: $718.6M$718.6MFY2023FY2024: $795.3M$795.3MFY2024FY2025: $895.6M$895.6MFY2025FY2026: $958.5M$958.5MFY2026

From CRVL's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 5). Last 12 months adds up the four latest quarters.

Next report
Feb 2
Estimated date · Before the open
Reported EPS
$0.67
Quarter ended Sep 2026
Year ago EPS
$0.54
+24.1% on a GAAP basis
Revenue
$267.1M
+11.5% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.46Dec '24Mar 2025: $0.51Mar '25Jun 2025: $0.52Jun '25Sep 2025: $0.54Sep '25Dec 2025: $0.47Dec '25Mar 2026: $0.61Mar '26Jun 2026: $0.63Jun '26Sep 2026: $0.67Sep '26Latest $0.67
Revenue by quarter
Dec 2024: $228.0MDec '24Mar 2025: $231.5MMar '25Jun 2025: $234.7MJun '25Sep 2025: $239.6MSep '25Dec 2025: $235.6MDec '25Mar 2026: $248.5MMar '26Jun 2026: $259.9MJun '26Sep 2026: $267.1MSep '26Latest $267.1M
How CRVL moved after its last 8 reports
Average move the session after a report ±7.1%
Nov 3, 2026Before the open−0.7%
Aug 4, 2026After the close+5.9%
May 19, 2026After the close+9.3%
Feb 3, 2026Before the open−26.1%
Nov 4, 2025Before the open+4.0%
Aug 4, 2025After the close+1.3%
May 21, 2025After the close+2.0%
Feb 4, 2025Before the open+7.5%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on CRVLStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Technical Analysis

CRVL · as of the Nov 20 close · updated each morning
Uptrend, nearing overbought

The stock is 4% above its 20 day and 10% above its 50 day average. It is 28% above its 200 day average, so the longer trend is still up. Momentum is strong (RSI 65), near overbought. The nearest support is the Pivot S1 at $87.51, and the nearest resistance the Pivot at $88.66.

Short trendBullish
Long trendBullish
MomentumStrong
StretchNear overbought
VolatilityNormal, 3.0%/day
Key levels
$90.7152 week high+2.8%
$89.76Swing high (Nov 5)+1.7%
$89.43Pivot R1+1.3%
$88.66Pivot+0.4%
$88.28Last close
$87.51Pivot S1−0.9%
$84.8620 day average−3.9%
$81.84Swing low (Nov 10)−7.3%
$79.6350 day average−9.8%
$72.12100 day average−18.3%
$63.99200 day average−27.5%
$44.8352 week low−49.2%
Indicators
RSI (14)64.65Strong, overbought above 70Neutral
MACD2.39Above its signal lineBullish
Stochastic78.0Middle of its rangeNeutral
ADX (14)22.5Weak trend
Williams %R-21.1Oversold below −80, overbought above −20Neutral
CCI (20)123.5Oversold below −100, overbought above 100Overbought
Rate of change+6.2%Change over 10 sessionsBullish
ATR (14)$2.61Typical daily range, 3.0% of price
MA 10Above
MA 20Above
MA 50Above
MA 100Above
MA 200Above
What happened before, for CRVL

What happened before

See how CRVL did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow CRVL usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How CRVL has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for CRVLHow many large options trades hit CRVL, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

CRVL Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Bullish
Strongly bearishNeutralStrongly bullish
  • ▲157 buying vs 115 selling
  • ●Held by funds -0.4 pts
  • ▲Funds holding +15
  • ▲Superinvestors: 3 added, 2 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding304289+5.2%
In funds' top 10110.0%
Held by funds54.9%55.3%−0.4 pts
New / increased44 / 11337 / 129−5.4%
Reduced / sold out91 / 2470 / 29+16.2%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See CRVL institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

CRVL Insider Trading

All filings →
Insider trading · 12 months
Insiders are only selling
Bought$00 buys · 0 insiders
Sold$22.5M18 sales · 8 insiders
77% of the selling was under pre-arranged trading plans.
2026-02 sold $956K2026-03 sold $562K2026-05 sold $122K2026-06 sold $2.4M2026-08 sold $349K2026-09 sold $15.9M2026-11 sold $2.2MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 16Mark E. BertelsEVP - Risk Management ServicesSale5,847$87.50$512K
Nov 13Jennifer YossVice President of AccountingSale2,100$86.48$182K
Nov 11Steven J HamerslagDirectorSale11,000$84.04$924K
Nov 9R Judd JessupDirectorSale6,939$83.01$576K
Sep 14Corstar Holdings Inc10% ownerSale plan158,749$69.94$11.1M
Sep 4Corstar Holdings Inc10% ownerSale plan66,251$68.88$4.6M
Every insider buy and sale for CRVL over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See CRVL insider trades →

From SEC Form 4 filings by CRVL's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CRVL is in one of them and how their past CRVL trades turned out.

CRVL in the AI portfolios
Loading…

CRVL News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered CRVL in an article yet. Here's the latest on the wider market.

CRVL in the news

About Corvel

CorVel provides medical cost management services that help control the rising costs of workers' compensation, auto insurance and group health claims. Its offerings include bill review, a network of healthcare providers, case and utilization management, pharmacy services and related claims tools, using artificial intelligence and other software to review medical bills and track care. Its customers include insurance companies, claims administrators, government agencies and employers that handle their own claims. The company is based in Fort Worth, Texas.

Headquarters
Portland, OR
Founded
1988